245 related articles for article (PubMed ID: 30891959)
1. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
[TBL] [Abstract][Full Text] [Related]
2. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.
Boppudi S; Bögershausen N; Hove HB; Percin EF; Aslan D; Dvorsky R; Kayhan G; Li Y; Cursiefen C; Tantcheva-Poor I; Toft PB; Bartsch O; Lissewski C; Wieland I; Jakubiczka S; Wollnik B; Ahmadian MR; Heindl LM; Zenker M
Clin Genet; 2016 Oct; 90(4):334-42. PubMed ID: 26970110
[TBL] [Abstract][Full Text] [Related]
3. Identification of Codon 146
Beyens A; Dequeker L; Brems H; Janssens S; Syryn H; D'Hooghe A; De Paepe P; Vanwalleghem L; Stockman A; Vankwikelberge E; De Schepper S; Goeteyn M; Delbeke P; Callewaert B
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409398
[TBL] [Abstract][Full Text] [Related]
4. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
[TBL] [Abstract][Full Text] [Related]
5. Oculoectodermal Syndrome - Encephalocraniocutaneous Lipomatosis Associated with NRAS Mutation.
Richters RJH; Seyger MMB; Meeuwis KAP; Rinne T; Eijkelenboom A; Willemsen MA
Acta Derm Venereol; 2020 Apr; 100(8):adv00103. PubMed ID: 31633190
[No Abstract] [Full Text] [Related]
6. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
7. Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.
Bennett JT; Tan TY; Alcantara D; Tétrault M; Timms AE; Jensen D; Collins S; Nowaczyk MJM; Lindhurst MJ; Christensen KM; Braddock SR; Brandling-Bennett H; Hennekam RCM; Chung B; Lehman A; Su J; Ng S; Amor DJ; ; ; Majewski J; Biesecker LG; Boycott KM; Dobyns WB; O'Driscoll M; Moog U; McDonell LM
Am J Hum Genet; 2016 Mar; 98(3):579-587. PubMed ID: 26942290
[TBL] [Abstract][Full Text] [Related]
8. Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations.
Peacock JD; Dykema KJ; Toriello HV; Mooney MR; Scholten DJ; Winn ME; Borgman A; Duesbery NS; Hiemenga JA; Liu C; Campbell S; Nickoloff BP; Williams BO; Steensma M
Am J Med Genet A; 2015 Jul; 167(7):1429-35. PubMed ID: 25808193
[TBL] [Abstract][Full Text] [Related]
9. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis.
Barry KK; Liang MG; Balkin DM; Srivastava S; Church AJ; Eng W
Pediatr Dermatol; 2024; 41(1):76-79. PubMed ID: 37486073
[TBL] [Abstract][Full Text] [Related]
11. Giant Ocular Lipodermoid Cyst in Encephalocraniocutaneous Lipomatosis: Surgical Treatment and Genetic Analysis.
Córdoba A; Graue-Hernández EO; Navas A; Chacon-Camacho OF; Zenteno JC; Ramirez-Miranda A; Bermudez-Magner JA; Ordaz-Robles T; Pérez-Solórzano S; Olivo-Payne A
Am J Case Rep; 2019 Oct; 20():1566-1571. PubMed ID: 31649234
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of FGFR1 N546K mosaic mutation in patient with encephalocraniocutaneous lipomatosis and pilocytic astrocytoma.
Kordacka J; Zakrzewski K; Gruszka R; Witusik-Perkowska M; Taha J; Sikorska B; Liberski PP; Zakrzewska M
Am J Med Genet A; 2019 Aug; 179(8):1622-1627. PubMed ID: 31173478
[TBL] [Abstract][Full Text] [Related]
14. Novel findings and expansion of phenotype in a mosaic RASopathy caused by somatic KRAS variants.
Chang CA; Perrier R; Kurek KC; Estrada-Veras J; Lehman A; Yip S; Hendson G; Diamond C; Pinchot JW; Tran JM; Arkin LM; Drolet BA; Napier MP; O'Neill SA; Balci TB; Keppler-Noreuil KM
Am J Med Genet A; 2021 Sep; 185(9):2829-2845. PubMed ID: 34056834
[TBL] [Abstract][Full Text] [Related]
15. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
[TBL] [Abstract][Full Text] [Related]
16. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas.
Valera ET; McConechy MK; Gayden T; Rivera B; Jones DTW; Wittmann A; Han H; Bareke E; Nikbakht H; Mikael L; Queiroz RG; Suazo VK; Phi JH; Kim SK; Park SH; Fukaya R; Yum MS; Ko TS; de Oliveira RS; Machado HR; Brassesco MS; do Santos AC; Simão GN; Ramalho LNZ; Neder L; Scrideli CA; Tone LG; Majewski J; Jabado N
Acta Neuropathol; 2018 Oct; 136(4):657-660. PubMed ID: 30143858
[No Abstract] [Full Text] [Related]
17. [Segmental overgrowth syndromes and therapeutic strategies].
Venot Q; Canaud G
Med Sci (Paris); 2020 Mar; 36(3):235-242. PubMed ID: 32228842
[TBL] [Abstract][Full Text] [Related]
18. Schimmelpenning-Feuerstein-Mims syndrome with orbital choristoma and
Yeager LB; Casper DS; Del Portillo A; Marr BP
Ophthalmic Genet; 2023 Dec; ():1-6. PubMed ID: 38097938
[TBL] [Abstract][Full Text] [Related]
19. Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension.
McDonell LM; Leung GK; Daoud H; Ip J; Chim S; Luk HM; Lan L; ; Boycott KM; Chung BH
Am J Med Genet A; 2018 Nov; 176(11):2523-2527. PubMed ID: 30289595
[No Abstract] [Full Text] [Related]
20. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
